Robert Brenner

CIK 2006910 · View on SEC EDGAR ↗

Insider

First SEC filing: Jan. 8, 2024 · Latest: Jan. 8, 2024

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 1 non-open-market transaction below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Jan. 3, 2024 VERA A 350,000 350,000 Direct Acquired (price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Jan. 3, 2024 VERA Stock Option (right to buy) Class A Common Stock (350,000) $15.36 Jan. 2, 2034 350,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Jan. 8, 2024 VERA No securities beneficially owned 0 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

VERA

M.D. Chief Medical Officer(1)
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2025 $509,000 $784,942 $1,137,870 $285,040 $3,000 $2,719,852
2024 $476,615 $120,000 $3,627,050 $229,138 $3,000 $4,445,802

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.